MDCXW
Medicus Pharma Ltd. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-0.91
52W High
$4.10
52W Low
$0.59
50-Day MA
$2.50
200-Day MA
$2.50
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd. (MDCXW) is a forward-looking pharmaceutical company dedicated to the development and commercialization of innovative therapies that address pressing healthcare challenges. With a robust pipeline supported by cutting-edge research and development, Medicus Pharma employs advanced technologies to enhance patient outcomes while adhering to rigorous regulatory standards. Positioned strategically within the pharmaceutical landscape, the company's commitment to delivering pioneering healthcare solutions not only addresses evolving medical needs but also aims to provide significant long-term value for its shareholders.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -2981.00% |
| Return on Assets | -204.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.00 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $32.82M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 5/5/2026